{"database": "lobbying", "table": "lobbying_activities", "rows": [[1346518, "c3fad43c-d400-4556-861e-3be1b880c455", "Q4", "BROWN RUDNICK LLP", 287895, "HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC", 2012, "fourth_quarter", "PHA", "H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; S.2297 relating to hydrocodone rescheduling.\nH.R. 5853 - Gray Market Drug Reform and Transparency Act of 2012", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2013-01-18T17:04:50.850000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1346518"], "units": {}, "query_ms": 0.3703190013766289, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}